Verastem (VSTM) Accumulated Expenses (2011 - 2026)

Verastem's Accumulated Expenses history runs 16 years deep, the most recent figure standing at $51.0 million for Q1 2026.

• In Q1 2026, Accumulated Expenses rose 1486.86% year-over-year to $51.0 million; the TTM figure through Mar 2026 stood at $51.0 million (up 1486.86% YoY), while the FY2025 annual figure was $54.0 million, up 108.0% from the prior year.
• Accumulated Expenses was $51.0 million for Q1 2026 at Verastem, down from $54.0 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $54.0 million in Q4 2025 to a low of $6000.0 in Q1 2022.
• Historically, Accumulated Expenses has averaged $12.4 million across 5 years, with a median of $4.8 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Accumulated Expenses slumped 99.93% in 2022, then jumped 232200.0% in 2023.
• A 5-year view of Accumulated Expenses shows it stood at $15.0 million in 2022, then plunged by 67.99% to $4.8 million in 2023, then jumped by 441.12% to $26.0 million in 2024, then surged by 108.0% to $54.0 million in 2025, then slipped by 5.61% to $51.0 million in 2026.
• The last three Accumulated Expenses figures came in at $51.0 million (Q1 2026), $54.0 million (Q4 2025), and $7.8 million (Q3 2025), per Business Quant data.